News | October 13, 2010

FDA Clearance Announced for Imager for IGRT

October 13, 2010 — The U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance for the new RAD II kilovoltage (KV) imager for image-guided radiation therapy (IGRT). The RAD II KV imager can be mounted on virtually any model of linear accelerator.

The new KV imager, which is driven by TheraView software, provides high-quality X-ray images for maximum clinical efficiency and resolution. It is a product evolution of the legacy MV (mega-voltage) imaging product line. It seamlessly integrates with existing TheraView electronic portal imaging devices (EPIDs), as well as with linear accelerators that have other brands.

TheraView imaging systems are manufactured by Cablon Medical BV in The Netherlands, and the RAD II KV imager is manufactured by Acceletronics Digital Imaging LLC. in the United States. The TheraView KV imager is distributed and serviced by Acceletronics Inc., Radiology Oncology Systems (ROS) and Cablon.

For more information: www.theraviewusa.com

Related Content

First GammaTile Therapy Case Completed in Arizona
News | Radiation Therapy | August 19, 2019
HonorHealth Scottsdale Osborn Medical Center is the first hospital in Arizona to begin offering GammaTile Therapy, a...
Drug Accelerates Blood System's Recovery After Radiation, Chemotherapy

Following radiation, the bone marrow shows nearly complete loss of blood cells in mice (left). Mice treated with the PTP-sigma inhibitor displayed rapid recovery of blood cells (purple, right). Credit: UCLA Broad Stem Cell Research Center/Nature Communications

News | Radiation Therapy | August 16, 2019
A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem...
Mevion and C-RAD Release Integration for Improved Proton Therapy Treatment Quality

Catalyst PT image courtesy of C-RAD

News | Patient Positioning Radiation Therapy | August 15, 2019
Mevion Medical Systems and C-RAD announced the integration between the C-RAD Catalyst PT and the Mevion S250i proton...
First Patient Enrolled in World's Largest Brain Cancer Clinical Trial
News | Radiation Therapy | August 15, 2019
Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive...
Efficacy of Isoray's Cesium Blu Showcased in Recent Studies
News | Brachytherapy Systems | August 14, 2019
August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medica
Videos | Radiographic Fluoroscopy (RF) | August 09, 2019
Shimadzu displayed the FluoroSpeed X1 conventional radiographic fluoroscopy (RF) system at the Association for Medica
Shimadzu Medical Systems Receives FDA 510(k) for FluoroSpeed X1 RF System
Technology | Radiographic Fluoroscopy (RF) | August 09, 2019
Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corp., announced they have received U.S. Food and Drug...
MD Anderson to Expand Proton Therapy Center

The MD Anderson Proton Therapy Center expansion is expected to be completed in 2023. Rendering courtesy of Stantec.

News | Proton Therapy | August 08, 2019
The University of Texas MD Anderson Cancer Center unveiled plans to expand its Proton Therapy Center during a...
Qfix kVue One Proton Couch Top Validated by Mevion Medical Systems
News | Patient Positioning Radiation Therapy | August 07, 2019
Qfix and Mevion Medical Systems announced that a special version of the kVue One Proton couch top is now both validated...